You need to upgrade your Flash Player

CELL THERAPEUTICS INC (CTIC) 1.08 red arrow -$0.03 (-2.70%) 09:13PM (15 mins delay)


CTIC
$1.08    -$0.03  (-2.70%)

You need to upgrade your Flash Player
Today 5d 1m 3m 1y 5y 10y
Last: $1.08 High: -
Prev Close: $1.11 Low: -
Open: - Mkt Cap: $638M
Change: -$0.03 ( -2.70% ) 52Wk High: $2.23
Vol: 0 52Wk Low: $0.05
Avg Volume: 9,329,902 Shares: 574.42B
EPS: 6.48 PE Ratio: 0.17

Start trading CTIC with real money!

Company Description

The Company focuses on the development, acquisition and commercialization of drugs for the treatment of cancer.

What do you think about CTIC?

140 characters max. Total left: 140
Also post on Twitter. (What is Twitter?)

Comments on CTIC

Charles C Murray via Twitter
Nov 18 4:05 PM
Ding Ding Ding little slow today was studing $ctic for a posisble recommendation
Comment
Charles C Murray via Twitter
Nov 18 3:53 PM
$ctic is .02c from crossing its 50 sma and is 6% above 200 sma
Comment
Charles C Murray via Twitter
Nov 18 3:43 PM
$ctic has a zabacus score of 5.8 hoilding in an upward trend
Comment
Charles C Murray via Twitter
Nov 18 3:38 PM
$ctic is on the move and has large up side potential for a retrace
Comment
vince bergado via Twitter
Nov 18 2:58 PM
$ctic looks tempting
Comment
Leigh Jones via Twitter
Nov 18 11:10 AM
Hope somebody else is enjoying $FRE $FNM scalps(remember I keep these plus $CTIC, $RTK, $DSCO, etc in my pocket 2 trd on dys they move!)
Comment
Leigh Jones via Twitter
Nov 18 9:50 AM
@fiestababy @copperstl Thank you! $CTIC /my pleasure! we have to hatch it somewhat --but still nice
Comment
Jason Park via Twitter
Nov 18 9:44 AM
@copperstl Thank you! $CTIC
Comment

CELL THERAPEUTICS INC (CTIC) Stock News & Analysis

stock news Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group Yesterday PR Newswire
stock news BrainStorm Stem Cell Therapy Technology Possesses Promising Potential for the Future Treatment of Multiple Sclerosis 11/16/2009 Business Wire
stock news RidgewaterEquity.com Free Fundamental Sector & Market Research on NITE, TIBX, CTIC, KLAC, BMRN and ETFC 11/16/2009 Marketwire
stock news BrainStorm Chief Medical Advisor Interviewed on Israel Radio Broadcast; States Stem Cell Therapy Treatment Ready For Clinical Trials 11/11/2009 Business Wire
stock news BrainStorm Stem Cell Therapy Treatment Shown To Be More Effective Than Other Current Potential Stem Cell Treatments 11/09/2009 Business Wire
stock news Cell Therapeutics Decreases Net Loss for Nine Month Period in 2009 Compared to Same Period in 2008 by 45% 11/05/2009 PR Newswire
stock news Trading Review for Cell Therapeutics Incorporated Issued by Beacon Equity 11/02/2009 GlobeNewswire
stock news Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on November 5 11/02/2009 PR Newswire
stock news Cell Therapeutics, Inc.'s (CTI) Presentation at BIO Investor Forum to be Webcast 10/29/2009 PR Newswire
stock news BrainStorm Granted "Outperform" Rating by Murphy Analytics 10/27/2009 Business Wire
stock news RothmanResearch.com Market Review and Company Analysis on MRVL, DRYS, CDNS, ILMN, CYOU and CTIC 10/27/2009 Marketwire
stock news Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum 10/26/2009 PR Newswire
stock news Spectrum Pharma: Zevalin Has Blockbuster Potential 10/25/2009 Seeking Alpha
stock news Pixantrone Produces High Rates of Complete Remission in Multiple Relapsed and Refractory Indolent and Aggressive Non-Hodgkin's Lymphoma 10/22/2009 PR Newswire
stock news Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders 10/21/2009 PR Newswire

Write Your Own Stock Analysis

Do you have a hot tip on a stock? Share it with our community. Get started by entering the company name or symbol below.

New CTIC Stock Picks

stock pick type healtcare sector
Posted 194 days ago on 5/11/09 by Charles Kassicieh
stock pick type Going to .20-.30 within a week.
Posted 297 days ago on 1/28/09 by Steve Rozenblat


Make a suggestion for this page

Investing Channel Logo

Data powered by QuoteMedia (Terms of Use). Data delayed 15 minutes unless otherwise indicated.